PGE2 Blockade Prevents CSC Repopulation and Bladder Cancer Chemoresistance

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-rw2014-255
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors

Unknown

Publisher

American Association for Cancer Research (AACR)

Related search

Unwrapping the Genomic Characteristics of Urothelial Bladder Cancer and Successes With Immune Checkpoint Blockade Therapy

Oncogenesis
Cancer ResearchMolecular Biology
2018English

Systemic Blockade of the Hyaluronan Receptor for Endocytosis Prevents Lymph Node Metastasis of Prostate Cancer

International Journal of Cancer
Cancer ResearchOncology
2012English

Estrogen Receptor Alpha Prevents Bladder Cancer via INPP4B Inhibited Akt Pathway in Vitro and in Vivo

Oncotarget
Oncology
2014English

Long Noncoding RNA LBCS Inhibits Self-Renewal and Chemoresistance of Bladder Cancer Stem Cells Through Epigenetic Silencing of SOX2

Clinical Cancer Research
Cancer ResearchOncology
2018English

EGFR Blockade Prevents Glioma Escape From BRAFV600E Targeted Therapy

Oncotarget
Oncology
2015English

Capsaicin Triggers Autophagic Cell Survival Which Drives Epithelial Mesenchymal Transition and Chemoresistance in Bladder Cancer Cells in an Hedgehog-Dependent Manner

Oncotarget
Oncology
2016English

AKT/PKB Signaling Mechanisms in Cancer and Chemoresistance

Frontiers in Bioscience - Landmark
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2005English

Bladder Cancer

Nature
Multidisciplinary
2017English

KDM5 Demethylases and Their Role in Cancer Cell Chemoresistance

International Journal of Cancer
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy